EX-8.1
Published on
Exhibit 8.1
Company Subsidiaries
Novogen Limited is a company limited by shares and is incorporated and domiciled in Australia. Novogen Limited has prepared a consolidated financial report incorporating the entities that it controlled during the financial year ended June 30, 2013, which included the following:
| Equity holding | ||||||||||||
| Name of entity |
Country of incorporation | 2013+ % |
2012+ % |
|||||||||
| Novogen Laboratories Pty Ltd |
Australia | 100.00 | 100.00 | |||||||||
| Novogen Research Pty Ltd |
Australia | 100.00 | 100.00 | |||||||||
| Novogen North America Inc. |
United States of America | 100.00 | — | |||||||||
| Triaxial Pharmaceuticals Pty Ltd |
Australia | 100.00 | — | |||||||||
| Novogen Inc. |
United States of America | 100.00 | 100.00 | |||||||||
| Glycotex, Inc. |
United States of America | — | 99.70 | |||||||||
| MEI Pharma, Inc.* |
United States of America | — | 63.50 | |||||||||
| * | Formerly known as Marshall Edwards Inc. |
| + | Ownership % at June 30, 2013 and 2012 respectively |